Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT07530094 · RECRUITING
Trial details
- NCT number
- NCT07530094
- Sponsor
- Ning Jiang, M.D./Ph.D.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.